PharmaDiagnostics appoints director of assay development

Former pharma department head joins Belgian firm

PharmaDiagnostics, a developer of label-free screening technology that does not require specialised instrumentation, has appointed Dr Sylviane Boucharens as director of assay development. She joins from Merck’s MSD site in Newhouse, Scotland, where she was head of global compound repository and in vitro screening.

Boucharens will play a central role in driving the growth of PharmaDiagnostics’ assay product range, and in developing business globally. She worked at Merck from 2000 to 2011. She started her career in the pharmaceutical industry in 1995 when she joined the Immunology Department in the Laboratoires Fournier (Dijon, France).

You may also like

Manufacturing

Reliable detection for high-temperature processes

ifm has launched the LMH point level sensor, a robust solution engineered for reliable medium detection in demanding industrial environments
Manufacturing

Nulogy launches Supplier Compliance Management to build stronger, more resilient supplier networks

Nulogy, a leading provider of manufacturing operations software, announced the launch of Nulogy Supplier Compliance Management, a solution designed to centralise and automate supplier compliance for procurement, supply chain, and quality assurance teams in manufacturing, food & beverage, pharmaceuticals, and other highly regulated industries
Manufacturing

Huber: Leading suppliers of world-class thermoregulation solutions

Since 1968, Huber has been at the forefront of technological advancement and continuous innovation in the field of liquid temperature control
Manufacturing

Hugo Beck launches sleeve wrapper for sustainable transport packaging

New paper S machine provides practical alternative to plastic and cardboard
Manufacturing

Concentrating recombinant proteins for drug discovery using centrifugal evaporation

Exploring purification, concentration and sample protection in recombinant protein workflows
Manufacturing

AQUARIA - enhancing drying performance while reducing consumption

AQUARIA stands out within the diverse range of parts washers for the pharmaceutical industry that have been developed by IMA over the last two decades. Designed to ensure maximum performance in cleaning and validation with high efficiency, AQUARIA is renowned for its reduced consumption of energy, water, detergents and compressed air. These qualities match the pharmaceutical industry’s current attention to environmental issues and prove how IMA is actively supporting sustainability across a wide spectrum of processes, where its solutions represent a respected benchmark
Manufacturing

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Subscribe now